Embedded Files
Current policy work at the Competence Centre of Microeconomic Evaluation (CC-ME)
Current policy work at the Competence Centre of Microeconomic Evaluation (CC-ME)
Aside from research, at the Competence Centre on Microeconomic Evaluation (CC-ME) we support European Commission and Member States policymakers in evaluating public policies using counterfactual impact evaluation methods. The main projects I am involved are:
Centre for Research on Impact Evaluation (CRIE)
I am currently coordinating CRIE, a partnership between the JRC and DG EMPL from the European Commission where we support European Social Fund (ESF) Managing Authorities in evaluating ESF-funded programmes. This support includes technical assistance, capacity building and policy evaluations.
If you want to check out the policy evaluations done by CRIE please visit our website here
Policy reports published with CRIE:
Serrano Alarcon, M., Indicators for measuring health outcomes in the context of the European Social Fund funded interventions, Publications Office of the European Union, Luxembourg, 2024, doi:10.2760/763929, JRC134555.
Haepp, T. and Serrano Alarcon, M., Meta-analysis of the European Social Fund counterfactual impact evaluations: Brief update with alternative measures, European Commission, Ispra, 2024, JRC137571.
Learning Lab on Investing in Quality Education and Training
I am part of the Learning Lab team, a partnership between the JRC and DG EAC from the European Commission that promotes education policy evaluation practices in the EU. We provide technical support and capacity building on counterfactual impact evaluation to EU Member States, including the realization of policy evaluations of specific education policies.
Check the Learning Lab website for more information: https://education.ec.europa.eu/focus-topics/improving-quality/learning-lab
Past examples of policy work
Past examples of policy work
Find below a few selected examples of policy work I have done outside the European Commission:
COVID-19 vaccine caravan in North Macedonia
COVID-19 vaccine caravan in North Macedonia
In collaboration with WHO North Macedonia and other researcher we evaluated the effectiveness of an information and vaccination caravan that aimed to increase COVID-19 vaccine uptake in North Macedonia. You can read more about the project in the WHO press release
Research paper from the evaluation:
"How to increase COVID-19 vaccination among a population with persistently suboptimal vaccine uptake? Evidence from the North Macedonia mobile vaccination and public health advice caravan" (with M. Mckee, L. Palumbo, C. Salvi, A. Johansen and D. Stuckler). Health Policy, 2023
A new model of Primary Care in Portugal
A new model of Primary Care in Portugal
In collaboration with the Portuguese Central Administration of the Health System (ACSS) and other researchers, we evaluated the effectiveness of a Primary care reform that introduced pay-for-performance incentives to Primary care doctors.
Research paper from the evaluation:
“Effect of a national Primary Care reform on avoidable hospital admissions (2000-2015): a difference-in-difference analysis” (with K. Dimitrovova & J. Perelman) Social Science & Medicine 2020
Long-term care and healthcare benefits in Catalonia
Long-term care and healthcare benefits in Catalonia
In collaboration with the Social Services department of the Catalan Government, AQUAS and other researchers at the Centre de Reserca en Economia i Salut (CRES) of Pompeu Fabra University, we study the impact of public long-term care benefits on healthcare utilization.
Main research paper of the project:
“Effects of long-term care benefits on healthcare utilization in Catalonia” (with HM. Hernández-Pizarro, C. Nicodemo and G. López-Casasnovas) Journal of Health Economics 2022
Cost-effectiveness of new medicines in Portugal
Cost-effectiveness of new medicines in Portugal
From 2018 to 2022, I served on the Health Technology Assessment Commission (CATS) of INFARMED, the Portuguese National Authority of Medicines and Health Products. Our role was to evaluate the cost-effectiveness studies submitted by pharmaceutical companies for the approval of new drugs to be funded by the Portuguese National Health Service.
Page updated
Google Sites
Report abuse